Lipoprotein storage disorders manifest as a heterogeneous group of rare metabolic diseases. These conditions are characterized by the accumulation of abnormal lipoproteins, primarily within the liver, leading to a spectrum of clinical manifestations. The underlying pathophysiology involve defects in